Clinical trial shows oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar, and even alcohol cravings.

Leave A Comment

Your email address will not be published. Required fields are marked *